Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer

被引:27
作者
Minard, Charles G.
Spitz, Margaret R.
Wu, Xifeng
Hong, Waun Ki
Etzel, Carol J.
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Unit 1340, Houston, TX 77030 USA
[2] Univ Texas, Hlth Sci Ctr, Sch Publ Hlth, Dept Biostat, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA
关键词
alcohol consumption; bleomycin-induced chromatid breaks per cell; glutathione S-transferase; mutagen sensitivity; second primary tumors; survival tree analysis; tobacco use;
D O I
10.1002/cncr.21928
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. The objective of this study was to evaluate the effects of polymorphisms in 2 genes in the glutathione S-transferase (GST) family and the mutagen-sensitivity phenotype on the risk of second primary tumors (SPTs) in patients with previously diagnosed early-stage head and neck squamous cell carcinoma. Data were available for 303 patients who were enrolled in a placebo-controlled chemo-prevention trial of low-dose 13-cis-retinoic acid to reduce the occurrence of SPTs. METHODS. A Cox proportional hazards model and survival tree analysis were used to evaluate the association between specified genetic variations and the development of SPTs. The average number of bleomycin-induced chromatid breaks per cell was used to quantify mutagen sensitivity as an individual patient's degree of sensitivity to genotoxicity. RESULTS. The GST-M1 null genotype was associated with an increased risk for any SPTs (hazard ratio [HR], 1.99; 95% confidence interval [95% CI], 1.11-3.56) and for tobacco-related SPTs (HR, 2.16; 95% CI, 1.01-4.62) after adjusting for covariates. The GST-T1 null genotype and bleomycin-induced chromatid breaks were not associated with a statistically significant increased risk for SPTs or tobacco-related SPTs after similar adjustment. Simultaneous nonnull status for both GST genotypes was associated with a decreased risk for any SPTs (HR, 0.52; 95% CI, 0.28-0.96) and tobacco-related SPTs (HR, 0.50; 95% CI, 0.22-1.11) compared with null status for GST-M1 accompanied by nonnull status for GST-T1. CONCLUSIONS. An association was observed between the development of SPTs and the GST-M1 null genotype after successful treatment for early-stage head and neck squamous cell carcinoma. The GST-T1 null genotype and bleomycin-induced chromatid breaks were not associated with an increased risk, and no significant interactions were identified.
引用
收藏
页码:2636 / 2644
页数:9
相关论文
共 67 条
[1]  
[Anonymous], 2005, Cancer facts and figures
[2]  
[Anonymous], 2001, SAS SYST WIND REL 8
[3]  
[Anonymous], 2003, CANC FACTS FIG
[4]   Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy [J].
Argiris, A ;
Brockstein, BE ;
Haraf, DJ ;
Stenson, KM ;
Mittal, BB ;
Kies, MS ;
Rosen, FR ;
Jovanovic, B ;
Vokes, EE .
CLINICAL CANCER RESEARCH, 2004, 10 (06) :1956-1962
[5]  
ATKINSON EJ, 2000, 61 MAY CLIN SECT STA
[6]  
BONGERS V, 1995, LAB INVEST, V73, P503
[7]  
Cheng L, 1999, INT J CANCER, V84, P220, DOI 10.1002/(SICI)1097-0215(19990621)84:3<220::AID-IJC4>3.0.CO
[8]  
2-S
[9]  
Cloos J, 2000, CANCER EPIDEM BIOMAR, V9, P713
[10]   INCREASED MUTAGEN SENSITIVITY IN HEAD-AND-NECK SQUAMOUS-CELL CARCINOMA PATIENTS, PARTICULARLY THOSE WITH MULTIPLE PRIMARY TUMORS [J].
CLOOS, J ;
BRAAKHUIS, BJM ;
STEEN, I ;
COPPER, MP ;
DEVRIES, N ;
NAUTA, JJP ;
SNOW, GB .
INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (06) :816-819